ACM
CRL icon

AlphaStar Capital Management’s Charles River Laboratories CRL Stock Holding History

AlphaStar Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-725
Closed -$257K – 387
2021
Q4 		$257K Buy
725
+110
+18% +$42.7K 0.02% 332
2021
Q3 		$257K Buy
615
+74
+14% +$30.7K 0.02% 327
2021
Q2 		$200K Buy
+541
New +$181K 0.03% 255

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaStar Capital Management's CRL Position: Q1 2022 in Review

AlphaStar Capital Management sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 725 shares — an estimated $257K sold.

AlphaStar Capital Management first reported a position in CRL in Q2 2021 and held it in 3 quarters. The position peaked at $257K in Q4 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • AlphaStar Capital Management reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • AlphaStar Capital Management sold 725 Charles River Laboratories shares in Q1 2022, an estimated $257K.
  • AlphaStar Capital Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 3 quarters.
  • AlphaStar Capital Management's Charles River Laboratories position peaked at $257K in Q4 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on AlphaStar Capital Management's 13F filing for Q1 2022, filed 28 Apr 2022.